Enter Details

Comment on stories, receive email newsletters & alerts.

This is your permanent identity for Business Insider Australia
Your email must be valid for account activation
Minimum of 8 standard keyboard characters


Email newsletters but will contain a brief summary of our top stories and news alerts.

Forgotten Password

Enter Details

Back to log in

Tagged With Pharmaceuticals

A startup searching for a drug to treat hearing loss just got an unusual endorsement from a big biotech

One of Allergan's blockbuster drugs was dealt a major legal blow

The Las Vegas shooter was reportedly prescribed a common anxiety medication -- here's what you need to know about it

The FDA just approved a 'complex generic drug' and it's sending one stock soaring and another crashing

A historian says all of sci-fi shares the same major flaw -- except one legendary novel

A drug-resistant malaria superbug is on the rise -- here's why that's so concerning

A biotech founded by a 32-year-old just failed a key Alzheimer's drug trial

California is close to passing legislation to tackle the rising cost of prescription drugs

The most respected medical journal in the US just eviscerated a drug that's cost taxpayers over $1 billion

A biotech CEO who sold his last company for $14 billion shares his best career advice

A lab-testing company just inked a billion-dollar deal for a healthcare company you've never heard of

Wall Street is making huge bets on healthcare companies you've never heard of

Here's how the CEO of a $50 billion drugmaker sees tech companies 'disrupting' healthcare

Why the CEO of a $50 billion company thinks you should look to Roger Federer for career inspiration

Here's what the 59-year-old CEO of a $50 billion healthcare company does to stay fit

The CEO of a $50 billion company explains why big-time dealmaking has dropped

Here's what the CEO of a $50 billion drug company wants out of health reform

Check out how the shorts have been piling into Wall Street's most hated pharma stock

Pharmacies take a $10 billion hit as Amazon lands Whole Foods deal

The chairman of the company behind the EpiPen reportedly flipped everyone off when they asked about drug pricing